CAR T-Cell Therapy
An advanced, highly specialized immune-cell approach in which T-cells are engineered to recognize specific targets — coordinated through a GMP-certified laboratory and a JCI-accredited hospital in Istanbul.
What is CAR T-Cell Therapy?
CAR T-cell therapy (Chimeric Antigen Receptor T-cell therapy) is one of the most advanced forms of cellular immunotherapy. T-cells — a type of immune cell — are collected and genetically engineered in the laboratory to express a chimeric antigen receptor that helps them recognize a specific target.
Once engineered and expanded, the modified T-cells are returned to the patient, where they are designed to seek out and act upon cells carrying that target. CAR T-cell therapy is a complex, tightly regulated intervention that requires rigorous clinical oversight.
StemCell Longevita is an international patient coordination platform. Because CAR T-cell therapy is highly specialized, we connect eligible patients with a GMP-certified laboratory and an experienced clinical team, and eligibility is determined strictly through detailed medical evaluation.
The Science Behind the Approach
T-Cell Collection
T-cells are collected from the patient's blood so they can be engineered in the laboratory.
Genetic Engineering
The T-cells are modified to express a chimeric antigen receptor (CAR) designed to recognize a specific target.
Expansion & Quality Control
Engineered cells are expanded in number and undergo rigorous quality control under GMP-certified conditions.
Supervised Reinfusion
The engineered cells are returned to the patient under close medical supervision, given the specialized nature of the therapy.
Potential Candidates
Before You Proceed
How the Process Works
Detailed Medical Evaluation
A thorough review of your diagnosis, history, and records determines whether CAR T-cell therapy may be appropriate.
T-Cell Collection
If eligible, your T-cells are collected so they can be engineered in the laboratory.
GMP Engineering & Expansion
Cells are genetically engineered, expanded, and rigorously quality-controlled in a GMP-certified facility.
Reinfusion & Close Monitoring
Engineered cells are reinfused under close medical supervision with structured monitoring and follow-up.
Pricing & Personalized Quotes
CAR T-cell therapy is a highly individualized and specialized intervention. Any pricing is confirmed only after eligibility is established through clinical evaluation, and a personalized quote is provided during that process.
Frequently Asked Questions
What is CAR T-cell therapy?
CAR T-cell therapy is an advanced form of immunotherapy in which a patient's T-cells are genetically engineered to express a chimeric antigen receptor (CAR) that helps them recognize a specific target before being returned to the patient.
Who is eligible for CAR T-cell therapy?
Eligibility is determined strictly through detailed clinical evaluation, including diagnostic and medical record review. Because it is highly specialized, it is appropriate only for carefully selected patients.
Is CAR T-cell therapy risky?
CAR T-cell therapy requires close medical monitoring. Potential risks and the safeguards in place are discussed thoroughly during your evaluation so you can make an informed decision.
Should I stop my current treatment for CAR T-cell therapy?
No. Any decision must be made together with your treating oncology or specialist team. This therapy is intended to be considered within, not as a replacement for, your overall care plan.